Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2021

Sep 14, 2021

31873_dirs_2021-09-13_b0d036d2-35ed-413e-bcd9-361ff82cf064.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-09-09

Reporting Person: Leproust Emily M. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-09 Common Stock M 15667 $8.82 Acquired 234810 Direct
2021-09-09 Common Stock S 15667 $119.0364 Disposed 219143 Direct
2021-09-10 Common Stock M 13920 $5.95 Acquired 233063 Direct
2021-09-10 Common Stock S 6331 $116.9214 Disposed 226732 Direct
2021-09-10 Common Stock S 3462 $117.7841 Disposed 223270 Direct
2021-09-10 Common Stock S 647 $118.4114 Disposed 222623 Direct
2021-09-10 Common Stock S 3480 $120.1413 Disposed 219143 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-09 Employee Stock Option (right to buy) $8.82 M 15667 Disposed 2027-09-28 Common Stock (15667) Direct
2021-09-10 Employee Stock Option (right to buy) $5.95 M 13920 Disposed 2025-09-28 Common Stock (13920) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $26.66 2028-11-18 Common Stock (0) 266539 Direct
Employee Stock Option (right to buy) $23.33 2029-10-23 Common Stock (0) 131290 Direct
Employee Stock Option (right to buy) $5.95 2025-09-28 Common Stock (0) 84613 Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $118.75 to $119.72 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $116.32 to $117.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $117.32 to $118.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $118.36 to $118.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $120.00 to $120.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F7: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F8: 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F9: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

F10: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.